Skip to main content
Year archive

Quantum Genomics — 2020 filings

All 31 regulatory filings released by Quantum Genomics (ALQGC) in 2020, sourced directly from the official regulator.

31 Filings
2020 Period
2020 filings (31)
Filing Released Lang
Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements
2020-12-17 French
Quantum Genomics Signs a Strategic Contract with Delpharm
Regulatory Filings
2020-12-16 English
Quantum Genomics signe un contrat stratégique avec Delpharm
Regulatory Filings
2020-12-16 French
Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Faran
Regulatory Filings
2020-12-15 French
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran
Regulatory Filings
2020-12-15 English
Vif succès du Placement Privé
Capital/Financing Update
2020-12-03 French
Very successfull Private Placement
Capital/Financing Update
2020-12-03 English
Quantum Genomics Strengthens its Capital Structure and Financial Visibility
Share Issue/Capital Change
2020-12-02 English
Quantum Genomics structure son capital et renforce sa visibilité financière
Capital/Financing Update
2020-12-02 French
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with DongWha Pharm
M&A Activity
2020-12-02 English
Quantum Genomics conclut un accord de licence et de collaboration exclusif avec DongWha Pharm
Regulatory Filings
2020-12-02 French
Fin du financement conclu avec Negma Group Ltd / Park Partners
Capital/Financing Update
2020-11-02 French
Quantum Genomics Announces End of Financing Agreement with Negma Group Ltd/Park Partners
Capital/Financing Update
2020-11-02 English
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Xediton Pharmaceuticals
Regulatory Filings
2020-10-28 English
Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Xediton Pharmaceuticals
Regulatory Filings
2020-10-28 French
Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Qilu Pharmaceutical
Regulatory Filings
2020-10-19 French
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutical
Capital/Financing Update
2020-10-19 English
2020 Half-year financial report
Interim / Quarterly Report H1 2020
2020-10-14 English
Rapport financier semestriel au 30 juin 2020
Interim / Quarterly Report H1 2020
2020-10-01 French
Quantum Genomics publie ses résultats du premier semestre 2020 et fait le point sur son activité
Interim / Quarterly Report H1 2020
2020-10-01 French
Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Orient EuroPharma (OEP)
Regulatory Filings
2020-09-22 French
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Orient EuroPharma (OEP)
Regulatory Filings
2020-09-22 English
Informations sur le contrat de financement avec Negma Group Ltd
Capital/Financing Update
2020-09-02 French
Quantum Genomics annonce le recrutement du premier patient dans l'étude FRESH, son étude pivot de phase III dans l'Hypertension Artérielle Difficile à Traiter/Résistante
Regulatory Filings
2020-07-13 French
Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension
Regulatory Filings
2020-07-13 English
Bilan semestriel du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont
Earnings Release H2 2020
2020-07-07 French
Quantum Genomics Appoints Benoît Gueugnon as Vice President of Finance
Board/Management Information
2020-01-28 English
Nomination de Benoît Gueugnon au poste de Vice-Président Finance
Board/Management Information
2020-01-28 French
Quantum Genomics to Present at the Gordon Research Conference 2020 Dedicated to the Renin Angiotensin Aldosterone System
Regulatory Filings
2020-01-15 English
Quantum Genomics fera une présentation à la Gordon Research Conference 2020 dédiée au Système Rénine Angiotensine Aldostérone
Regulatory Filings
2020-01-15 French
Bilan semestriel du contrat de liquidité au 31 décembre 2019
Capital/Financing Update
2020-01-06 French